// App-Quantinova.ai

: Temporal Echocardiographic Assessment of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib, Pirfenidone and Other Agents

Researchers

Presenter

  • M. Tahara

Principal Investigators

  • K. Oda

  • K. Yamasaki

  • K. Yatera

Medical Centers

  • Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan

  • Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Pulmonary arterial hypertension

  • Pulmonary fibrosis

  • Hypertension

Biomarkers

  • Carboxypeptidase B1

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved